Concepts (221)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Clostridium Infections | 27 | 2023 | 559 | 4.610 |
Why?
|
Bacterial Toxins | 25 | 2023 | 921 | 3.070 |
Why?
|
Enterotoxins | 20 | 2023 | 365 | 2.620 |
Why?
|
Saccharomyces | 5 | 2013 | 62 | 1.150 |
Why?
|
Feces | 13 | 2023 | 1511 | 1.110 |
Why?
|
Probiotics | 4 | 2016 | 382 | 0.870 |
Why?
|
Enterocolitis, Pseudomembranous | 8 | 2018 | 264 | 0.780 |
Why?
|
Carrier State | 3 | 2021 | 529 | 0.720 |
Why?
|
Antitoxins | 3 | 2023 | 75 | 0.700 |
Why?
|
Diarrhea | 7 | 2023 | 1319 | 0.660 |
Why?
|
Toll-Like Receptor 9 | 1 | 2020 | 199 | 0.650 |
Why?
|
Colitis | 2 | 2020 | 1244 | 0.620 |
Why?
|
Bacterial Proteins | 14 | 2022 | 3839 | 0.550 |
Why?
|
Virulence Factors | 1 | 2018 | 502 | 0.490 |
Why?
|
Capillary Permeability | 1 | 2018 | 773 | 0.490 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2018 | 3518 | 0.490 |
Why?
|
Intestinal Mucosa | 9 | 2019 | 3047 | 0.440 |
Why?
|
Vancomycin | 5 | 2018 | 505 | 0.430 |
Why?
|
Antibodies, Neutralizing | 3 | 2020 | 2009 | 0.410 |
Why?
|
Immunologic Factors | 1 | 2021 | 1597 | 0.380 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2013 | 550 | 0.350 |
Why?
|
Antibodies, Bacterial | 5 | 2022 | 1478 | 0.290 |
Why?
|
Anti-Bacterial Agents | 7 | 2020 | 7472 | 0.280 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 4 | 2013 | 474 | 0.250 |
Why?
|
Aminoglycosides | 2 | 2017 | 161 | 0.250 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 4 | 2013 | 478 | 0.250 |
Why?
|
Enteritis | 1 | 2006 | 164 | 0.240 |
Why?
|
Interleukin-1beta | 5 | 2023 | 1027 | 0.230 |
Why?
|
Mice | 19 | 2024 | 82074 | 0.200 |
Why?
|
Antibodies, Monoclonal | 2 | 2016 | 9264 | 0.200 |
Why?
|
Toxemia | 1 | 2020 | 14 | 0.180 |
Why?
|
Animals | 24 | 2024 | 169408 | 0.180 |
Why?
|
Fungi | 1 | 2023 | 345 | 0.180 |
Why?
|
Chemokine CCL3 | 1 | 2020 | 85 | 0.180 |
Why?
|
Macrophage Inflammatory Proteins | 1 | 2020 | 122 | 0.170 |
Why?
|
Signal Transduction | 6 | 2020 | 23652 | 0.170 |
Why?
|
Clinical Laboratory Techniques | 2 | 2015 | 749 | 0.170 |
Why?
|
MAP Kinase Signaling System | 1 | 2006 | 1494 | 0.160 |
Why?
|
Luminescent Proteins | 1 | 2002 | 839 | 0.160 |
Why?
|
Immunoassay | 2 | 2019 | 746 | 0.150 |
Why?
|
Endocytosis | 2 | 2005 | 959 | 0.150 |
Why?
|
DNA, Bacterial | 2 | 2020 | 1478 | 0.150 |
Why?
|
Transglutaminases | 1 | 2019 | 200 | 0.150 |
Why?
|
Colonic Neoplasms | 2 | 2012 | 2543 | 0.150 |
Why?
|
Ecosystem | 1 | 2022 | 494 | 0.150 |
Why?
|
Hypoxia-Inducible Factor 1 | 1 | 2018 | 193 | 0.150 |
Why?
|
Microbiological Techniques | 1 | 2018 | 97 | 0.150 |
Why?
|
NF-kappa B | 4 | 2017 | 2492 | 0.140 |
Why?
|
Phosphorylation | 6 | 2017 | 8317 | 0.140 |
Why?
|
Colon | 4 | 2020 | 1804 | 0.140 |
Why?
|
Survival Analysis | 3 | 2018 | 10115 | 0.130 |
Why?
|
Neovascularization, Pathologic | 2 | 2018 | 2634 | 0.130 |
Why?
|
Cecum | 1 | 2016 | 231 | 0.130 |
Why?
|
Molecular Chaperones | 1 | 2020 | 763 | 0.130 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 4 | 2015 | 3814 | 0.120 |
Why?
|
Recombinant Fusion Proteins | 2 | 2013 | 3744 | 0.120 |
Why?
|
Protein Precursors | 1 | 2019 | 1135 | 0.120 |
Why?
|
Disease Models, Animal | 5 | 2020 | 18366 | 0.110 |
Why?
|
Epithelium | 1 | 2018 | 1607 | 0.110 |
Why?
|
Constipation | 1 | 2019 | 570 | 0.110 |
Why?
|
Ileum | 2 | 2014 | 558 | 0.110 |
Why?
|
Genome, Bacterial | 1 | 2018 | 796 | 0.110 |
Why?
|
Irritable Bowel Syndrome | 1 | 2019 | 455 | 0.110 |
Why?
|
Immunoglobulin A | 3 | 2023 | 992 | 0.110 |
Why?
|
Oxazolidinones | 1 | 2013 | 98 | 0.110 |
Why?
|
Sodium Dodecyl Sulfate | 1 | 2013 | 124 | 0.110 |
Why?
|
Spores, Bacterial | 1 | 2013 | 114 | 0.110 |
Why?
|
Toll-Like Receptor 5 | 1 | 2013 | 42 | 0.110 |
Why?
|
Humans | 37 | 2024 | 768887 | 0.110 |
Why?
|
Prospective Studies | 7 | 2023 | 54950 | 0.110 |
Why?
|
Phospholipase C gamma | 1 | 2013 | 131 | 0.100 |
Why?
|
Steroids | 1 | 2018 | 938 | 0.100 |
Why?
|
Flagellin | 1 | 2013 | 124 | 0.100 |
Why?
|
Receptors, Cell Surface | 1 | 2002 | 2820 | 0.100 |
Why?
|
Cathelicidins | 1 | 2012 | 81 | 0.100 |
Why?
|
Hypothalamic Hormones | 1 | 2012 | 145 | 0.090 |
Why?
|
Celiac Disease | 1 | 2019 | 820 | 0.090 |
Why?
|
Pituitary Hormones | 1 | 2012 | 182 | 0.090 |
Why?
|
Bacterial Vaccines | 1 | 2013 | 400 | 0.090 |
Why?
|
Salmonella typhimurium | 1 | 2013 | 348 | 0.090 |
Why?
|
Inpatients | 1 | 2022 | 2570 | 0.090 |
Why?
|
Melanins | 1 | 2012 | 292 | 0.090 |
Why?
|
Immunoglobulin G | 4 | 2023 | 4568 | 0.090 |
Why?
|
Mice, Inbred C57BL | 7 | 2018 | 22381 | 0.080 |
Why?
|
Intestinal Neoplasms | 1 | 2012 | 314 | 0.080 |
Why?
|
Inflammation | 5 | 2017 | 10869 | 0.080 |
Why?
|
Tumor Stem Cell Assay | 1 | 2009 | 116 | 0.080 |
Why?
|
Immunoenzyme Techniques | 2 | 2023 | 1705 | 0.080 |
Why?
|
Ribotyping | 2 | 2022 | 35 | 0.080 |
Why?
|
Adenoviridae | 1 | 2013 | 1095 | 0.080 |
Why?
|
Immunity, Humoral | 1 | 2013 | 610 | 0.080 |
Why?
|
Genes, APC | 1 | 2009 | 146 | 0.080 |
Why?
|
Intestines | 2 | 2018 | 1911 | 0.080 |
Why?
|
Immunity, Innate | 1 | 2020 | 3080 | 0.070 |
Why?
|
Flow Cytometry | 1 | 2018 | 5905 | 0.070 |
Why?
|
Anti-Inflammatory Agents | 2 | 2014 | 1813 | 0.070 |
Why?
|
Mice, Knockout | 2 | 2020 | 14485 | 0.070 |
Why?
|
Dysentery, Bacillary | 1 | 2007 | 73 | 0.070 |
Why?
|
Shigella flexneri | 1 | 2007 | 118 | 0.070 |
Why?
|
Mice, Nude | 1 | 2013 | 3631 | 0.070 |
Why?
|
Interleukin-8 | 2 | 2007 | 705 | 0.070 |
Why?
|
Epithelial Cells | 2 | 2017 | 3701 | 0.060 |
Why?
|
Diagnosis, Differential | 1 | 2021 | 13020 | 0.060 |
Why?
|
Female | 16 | 2021 | 397464 | 0.060 |
Why?
|
Tumor Necrosis Factor-alpha | 4 | 2017 | 4356 | 0.050 |
Why?
|
Fibroblasts | 1 | 2014 | 4178 | 0.050 |
Why?
|
Apoptosis | 4 | 2017 | 9528 | 0.050 |
Why?
|
Genetic Vectors | 1 | 2013 | 3414 | 0.050 |
Why?
|
Cell Line | 4 | 2017 | 15603 | 0.050 |
Why?
|
Electrophoresis, Gel, Pulsed-Field | 1 | 2022 | 142 | 0.050 |
Why?
|
Metronidazole | 2 | 2014 | 236 | 0.050 |
Why?
|
Recurrence | 3 | 2023 | 8512 | 0.050 |
Why?
|
Phenotype | 1 | 2020 | 16735 | 0.050 |
Why?
|
Transduction, Genetic | 1 | 2005 | 902 | 0.050 |
Why?
|
Capsid Proteins | 1 | 2005 | 468 | 0.050 |
Why?
|
Tumor Cells, Cultured | 1 | 2009 | 6131 | 0.050 |
Why?
|
Cricetinae | 2 | 2016 | 2423 | 0.050 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2016 | 2445 | 0.050 |
Why?
|
Receptors, Virus | 1 | 2005 | 652 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2009 | 2460 | 0.040 |
Why?
|
Administration, Oral | 1 | 2008 | 4042 | 0.040 |
Why?
|
Integrins | 1 | 2005 | 843 | 0.040 |
Why?
|
Chloride-Bicarbonate Antiporters | 1 | 2020 | 103 | 0.040 |
Why?
|
Longitudinal Studies | 1 | 2016 | 14795 | 0.040 |
Why?
|
Gene Expression Regulation | 2 | 2020 | 11934 | 0.040 |
Why?
|
Polysaccharides | 1 | 2006 | 1024 | 0.040 |
Why?
|
North America | 1 | 2022 | 1290 | 0.040 |
Why?
|
Transcription Factor RelA | 2 | 2013 | 254 | 0.040 |
Why?
|
Middle Aged | 8 | 2021 | 223740 | 0.040 |
Why?
|
Gene Expression | 2 | 2014 | 7602 | 0.040 |
Why?
|
Drug Therapy, Combination | 1 | 2008 | 6320 | 0.040 |
Why?
|
Mammals | 1 | 2023 | 1136 | 0.040 |
Why?
|
Receptors, Fc | 2 | 2014 | 538 | 0.040 |
Why?
|
Mutagenesis | 1 | 2002 | 1229 | 0.040 |
Why?
|
Haptoglobins | 1 | 2019 | 165 | 0.040 |
Why?
|
Male | 11 | 2021 | 365249 | 0.030 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2019 | 294 | 0.030 |
Why?
|
Permeability | 1 | 2019 | 726 | 0.030 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 2017 | 826 | 0.030 |
Why?
|
Green Fluorescent Proteins | 1 | 2002 | 2067 | 0.030 |
Why?
|
Immunization | 1 | 2020 | 1219 | 0.030 |
Why?
|
Immunohistochemistry | 1 | 2009 | 11119 | 0.030 |
Why?
|
Ligands | 1 | 2002 | 3283 | 0.030 |
Why?
|
Severity of Illness Index | 2 | 2013 | 15955 | 0.030 |
Why?
|
Mesocricetus | 1 | 2014 | 256 | 0.030 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2018 | 1048 | 0.030 |
Why?
|
Canada | 1 | 2019 | 2129 | 0.030 |
Why?
|
Binding Sites, Antibody | 1 | 2014 | 340 | 0.030 |
Why?
|
Proteome | 1 | 2024 | 1891 | 0.030 |
Why?
|
Injections, Intralesional | 1 | 2014 | 280 | 0.030 |
Why?
|
Cell Proliferation | 1 | 2009 | 10486 | 0.030 |
Why?
|
Adult | 7 | 2023 | 223818 | 0.030 |
Why?
|
Down-Regulation | 1 | 2020 | 2941 | 0.030 |
Why?
|
RNA, Messenger | 2 | 2020 | 12809 | 0.030 |
Why?
|
Organ Culture Techniques | 1 | 2014 | 796 | 0.030 |
Why?
|
Immunization, Passive | 1 | 2014 | 619 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2016 | 65485 | 0.020 |
Why?
|
Neutralization Tests | 1 | 2014 | 739 | 0.020 |
Why?
|
Acetamides | 1 | 2013 | 260 | 0.020 |
Why?
|
Peptides | 1 | 2024 | 4353 | 0.020 |
Why?
|
Caco-2 Cells | 1 | 2012 | 365 | 0.020 |
Why?
|
Fluoroquinolones | 1 | 2013 | 309 | 0.020 |
Why?
|
Neutrophil Infiltration | 1 | 2014 | 395 | 0.020 |
Why?
|
Receptors, Somatostatin | 1 | 2012 | 138 | 0.020 |
Why?
|
Dextran Sulfate | 1 | 2012 | 258 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2024 | 3591 | 0.020 |
Why?
|
Autoantibodies | 1 | 2019 | 2126 | 0.020 |
Why?
|
Vaccines, Synthetic | 1 | 2013 | 622 | 0.020 |
Why?
|
Edema | 1 | 2014 | 766 | 0.020 |
Why?
|
Cytokines | 2 | 2021 | 7453 | 0.020 |
Why?
|
Rats | 1 | 2006 | 23847 | 0.020 |
Why?
|
Protein Subunits | 1 | 2013 | 943 | 0.020 |
Why?
|
Cells, Cultured | 3 | 2013 | 19023 | 0.020 |
Why?
|
Wnt Proteins | 1 | 2012 | 725 | 0.020 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2014 | 1363 | 0.020 |
Why?
|
Cohort Studies | 2 | 2021 | 41800 | 0.020 |
Why?
|
Adjuvants, Immunologic | 1 | 2013 | 999 | 0.020 |
Why?
|
Aged | 5 | 2021 | 171790 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2013 | 2931 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2018 | 4784 | 0.020 |
Why?
|
Colony Count, Microbial | 1 | 2007 | 328 | 0.020 |
Why?
|
beta Catenin | 1 | 2012 | 1047 | 0.020 |
Why?
|
Microbial Sensitivity Tests | 1 | 2013 | 1963 | 0.020 |
Why?
|
Young Adult | 3 | 2019 | 60110 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 2013 | 1855 | 0.020 |
Why?
|
Tight Junctions | 1 | 2007 | 324 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2019 | 59738 | 0.020 |
Why?
|
Child | 2 | 2023 | 80969 | 0.010 |
Why?
|
Solubility | 1 | 2006 | 1087 | 0.010 |
Why?
|
Inflammation Mediators | 1 | 2012 | 1890 | 0.010 |
Why?
|
Electric Impedance | 1 | 2007 | 795 | 0.010 |
Why?
|
Gastric Mucosa | 1 | 2006 | 602 | 0.010 |
Why?
|
Antibody Formation | 1 | 2007 | 1393 | 0.010 |
Why?
|
Mice, SCID | 1 | 2007 | 2631 | 0.010 |
Why?
|
Cell Survival | 1 | 2012 | 5794 | 0.010 |
Why?
|
Interleukin-1 | 1 | 2006 | 1251 | 0.010 |
Why?
|
Adenoma | 1 | 2012 | 2164 | 0.010 |
Why?
|
Odds Ratio | 1 | 2013 | 9682 | 0.010 |
Why?
|
Blotting, Western | 1 | 2007 | 5035 | 0.010 |
Why?
|
Protein Transport | 1 | 2006 | 1956 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2015 | 14751 | 0.010 |
Why?
|
Child, Preschool | 1 | 2022 | 42684 | 0.010 |
Why?
|
Hot Temperature | 1 | 2006 | 1440 | 0.010 |
Why?
|
Stem Cells | 1 | 2012 | 3540 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2007 | 2395 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 2005 | 1973 | 0.010 |
Why?
|
HeLa Cells | 1 | 2005 | 3076 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2016 | 22294 | 0.010 |
Why?
|
Infant | 1 | 2020 | 36541 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2012 | 8664 | 0.010 |
Why?
|
Cell Movement | 1 | 2007 | 5216 | 0.010 |
Why?
|
Prognosis | 1 | 2016 | 30044 | 0.010 |
Why?
|
Disease Progression | 1 | 2012 | 13677 | 0.010 |
Why?
|
Neutrophils | 1 | 2007 | 3785 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 2012 | 6401 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2016 | 39394 | 0.010 |
Why?
|
Protein Binding | 1 | 2005 | 9344 | 0.010 |
Why?
|
DNA | 1 | 2006 | 7214 | 0.010 |
Why?
|
Adolescent | 1 | 2019 | 89247 | 0.010 |
Why?
|
Risk Factors | 1 | 2013 | 74971 | 0.000 |
Why?
|
Pregnancy | 1 | 2007 | 30175 | 0.000 |
Why?
|
Concepts
(221)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(19)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_